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Placental hypoxia, a major component of the pathophysiology of preeclampsia, is associated with various maternal 
vascular and endothelial dysfunctions. The higher incidence of preeclampsia at high altitude remains incompletely 
explained. The aim of the present study was to investigate the effect of high altitude on some endothelial and 
vascular dysfunction markers in normal and preeclamptic pregnancies. Eighty pregnant women (Paras 2–4) were 
enrolled in this study, which included four groups (each n = 20): normal pregnancies at low altitude (NL), normal 
pregnancies at high altitude (NH), preeclamptic pregnancies at low altitude (PL), and preeclamptic pregnancies at 
high altitude (PH). In normal pregnancies at high altitude serum ET-1, plasma TXA2, and serum TNF-α levels 
increased significantly with a significant reduction in plasma PGI2 (66.81 ± 7.36, 122.86 ± 13.37, 102.23 ± 13.31, 
191.57 ± 19.68, respectively) compared with the NL group (48.92 ± 4.58, 89.03 ± 10.67, 69.86 ± 7.97, 238.01 ± 
24.55, respectively). In preeclampsia at low altitude serum ET-1, plasma TXA2, and serum TNF-α levels increased 
significantly with a significant reduction in plasma PGI2 (88.39 ± 9.54, 162.73 ± 15.92, 142.39 ± 15.37, 149.155 ± 
15.66, respectively) compared with both NL and NH groups. High altitude significantly augmented these changes in 
preeclamptic patients (117.75 ± 12.96, 211.01 ± 22.69, 196.86 ± 17.64, 111.92 ± 10.74) compared with PL, NH and 
NL groups. In conclusion hypoxia at high altitude aggravated the disturbances in the levels of ET-1, TXA2, PGI2 and 
TNF-α associated with preeclampsia. This may contribute to the higher risk of preeclampsia at high altitude.
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Preeclampsia remains one of the leading causes of maternal and fetal morbidity. Recent 
research has revealed that placental insufficiency, resulting in hypoxia and ischemia, is a 
central causative pathway in the development of preeclampsia (10, 26). Despite thorough 
characterization of the preeclamptic syndrome and incrimination of a suite of contributing 
circulating factors (6, 15, 32), the mechanisms underlying the pathogenesis remain nebulous. 
Theories about etiological factors in preeclampsia include the reduction in uteroplacental 
blood flow, circulating factors of placental origin, placental oxidative stress and increased 
maternal vascular reactivity (32). The initiating event in preeclampsia is postulated to be 
reduced utero-placental perfusion as a result of an abnormal cytotrophoblast invasion of 
spiral arterioles. Placental ischemia is thought to lead to widespread activation/dysfunction 
of the maternal vascular endothelium. This enhances the formation of vasoactive factors like 
endothelin (ET-1) (13) and thromboxane A2 (TXA2) (22), as well as it increases vascular 
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sensitivity to angiotensin II, and decreases the formation of vasodilators such as nitrous oxide 
(17) and prostacyclin (PGI2) (13). Maternal endothelial cell activation/dysfunction enhances 
the synthesis of inflammatory cytokines such as tumor necrosis factor alpha (TNF-α). TNF-α 
has been shown to induce structural and functional alterations of placental endothelial cells 
during trophoblast development in preeclampsia (35). These endothelial abnormalities, in 
turn, cause hypertension by impairing renal-pressure and increasing total peripheral 
resistance. 
Studies indicate that the incidence of preeclampsia is increased by two- to fourfold at 
high altitude (> 2700 m) (20, 36). However, the link between maternal hypoxemia induced 
by residence at high altitude and the increased risk for preeclampsia is yet to be fully and 
satisfactorily explained despite a number of studies both at the morphological and molecular 
levels. Xiao et al. suggested that high altitude hypoxia altered uterine vessels myogenic 
activity via enhanced oxidative stress (34). Residence at high altitude per se was reported to 
induce significant elevation of several vasoconstriction relative to vasodilatation mediators 
(3, 18). This effect is apparently more pronounced during pregnancy, with greater levels of 
certain vasoconstrictor, inhibition of other vasodilator mediators, compared with low-altitude 
pregnancy. Zamudio suggested that the impact of hypoxia on several vasoactive 
mediators during pregnancy shifts the general population risk towards the development of 
preeclampsia (36).
The aim of the present study was to investigate the changes in some vasoactive agents 
associated with the preeclamptic syndrome at low altitude and determine whether residence 
at high altitude augments or aggravates the change in these factors.
Materials and Methods
Study design
This study followed the instructions in accordance with the ethical standards of the responsible 
committee on human experimentation and was adherent to the Helsinki Declaration of 1975, 
revised in 2000 (available at http://www.wma.net/e/policy/17-c_e.html). The study was 
proved by the Ethical Committee of the College of Medicine, King Khalid University, Saudi 
Arabia. 
Study subjects
The study was carried out in Aseer region in Southern of Saudi Arabia. Abha city was selected 
as high altitude (altitude 2700 m), while Muhayl city was selected as low altitude (altitude 
500 m). Eighty (selected randomly) pregnant women (Para 2 to 4) (the ages ranged between 
30–39 years) were included in this study who attended to the outpatient clinic in obstetrics 
and gynecology department in both Abha General Hospital and Muhayl General Hospital. An 
informed consent was obtained from each subject included in the study. Laboratory samples 
were collected at the time of diagnosis of preeclampsia (week 28–32) before any medication 
was prescribed.
The blood pressure in the normotensive group ranged between 110/70 – 120/80 mmHg 
and in the hypertensive group ranged between 160/90 – 175/105 mmHg (three separate 
readings were taken at least six hours apart). Diagnosis of proteinuria was confirmed by the 
presence of 0.3 grams or more protein in a 24-hour urine sample in preeclamptic patients. 
The subjects were divided into 2 main groups, the first main group was pregnant women 
who attended Abha General Hospital (40 pregnant women) which included two subgroups: 
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(a) Healthy pregnant control (20) and (b) preeclamptic pregnant patients (20). The second 
main group who attended Muhayl General Hospital (40) included two subgroups: (a) Healthy 
pregnant control (20) and (b) preeclamptic pregnant women (20). All participants were 
subjected to history taking and clinical examination. Exclusion criteria among the participants 
included any serious medical problems such as diabetes or renal or liver affection. Abdominal 
ultrasound was done for all the participants to assess the liver, the portal vein diameter, the 
spleen size and the presence or absence of ascites, renal disorders or any other abnormalities. 
Obstetric ultra-sonography was done by a specialist to exclude any obstetric abnormalities 
and multiple pregnancies. Three readings for the blood pressure were taken using the ordinary 
sphygmomanometer technique and urinary proteinuria was measured using commercial kits 
for detection of the proteinuria.
Blood sampling
Three venous blood samples were obtained from participants in three visits over one week 
interval (1 ml/ sample). Samples were divided into two parts; the first parts were allowed to 
clot for 20 min, and centrifuged at 14,000 rpm for 10 min. Serum was separated and used for 
determination of creatinine, serum urea, ET-1 and TNFα levels. The other parts of the blood 
were added to ethylene diamine tetra-acetic acid (EDTA) and centrifuged at 1,000 rpm for 
15 min. Plasma was separated and stored at –80 °C for assay of the total plasma nitrite/nitrate 
(NOx), PGI2 and TXA2 levels. The mean of three readings was taken for each subject.
Determination of serum urea and creatinine levels
Serum urea level was determined by the enzymatic colorimetric method using a specialized 
kit. The method is based on urease (urea amidohydrolase) / glutamate dehydrogenase coupled 
reactions and uses a two-point fixed time, kinetic scheme for monitoring the rate of 
consumption of NADH at 340 nm (7). Serum creatinine level was determined by the Jaffe 
reaction, where creatinine reacts with picrate ion in an alkaline medium to yield an orange red 
complex, which was measured at 490 nm (29).
Determination of serum ET-1, plasma PGI2 and TXA2 levels 
Serum level of ET-1 was determined using a commercially available sandwich ELISA kit 
following the instructions of the manufacturer (USCN Life and Technology). The measurable 
range of ET-1 was 15.6 to 1,000 pg/ml. The intra-assay and inter-assay coefficients of 
variation were 5.6 and 11%, respectively. Plasma levels of PGI2 and TXA2 were measured by 
their stable metabolites of 6-keto-PGF1α and TXB2 by enzyme-linked immunosorbent assay 
(ELISA). Both 6-keto-PGF1α and TXB2 ELISA kits were purchased from Oxford Biomedical 
Research, Ins. (Oxford, MI, USA). Plasma samples for measurements of 6-keto-PGF1α and 
TXB2 were extracted by C18 Sep-Pak column (Waters Corporation, Milford, MA, USA) 
following the standard manufacture instruction before assay.
Determination of plasma NOx, serum tumor necrosis factor-alpha (TNFα) levels 
The method for the estimation of the plasma NOx level, the metabolites of vasodilator nitrous 
oxide, was based on the Griess reaction. Plasma nitrite/nitrate levels were measured after 
the enzymatic conversion of nitrate to nitrite by nitrate reductase in the presence of NADPH. 
The oxidation of the coenzyme was monitored by the decrease in absorbance at 540 nm. The 
results were expressed as micromole per liter (16). Serum TNF-α level was determined by 
cytotoxicity on L929 cells using recombinant TNF-α (BASF/Knoll, Ludwigshafen, Germany; 
specific activity, 107 U/mg) and expressed in picogram per milliliter (5)
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Statistical analysis
The data was expressed as means ± SD. The Kolmogorov–Smirnov test was used to ensure 
the normality of the distribution of the data. Testing significance was performed using χ2 test 
and the one-way analysis of variance (ANOVA). The post hoc Scheffe’s test was applied to 
identify the source of statistical significance. P values less than 0.05 were considered 
statistically significant.
Results
Determination of blood pressure
The blood pressures in preeclamptic patients of both low and high altitude showed significant 
elevation of systolic (171.45 ± 19.76, 182.05 ± 18.94, respectively) and diastolic blood 
pressures (118.95 ± 12.26, 127.20 ± 12.47, respectively) compared with the normal pregnant 
women for systolic (117.05 ± 12.17, 111.30 ± 13.62, respectively) and diastolic blood 
pressures (72.55 ± 7.43, 72.10 ± 9.87 respectively). There were not any significant changes 
in both SBP and DBP in preeclamptic patients in high altitude compared with low altitude 
patients (Table I).
Table I. Showed mean ± SD for the age, parity, gestational age (GA), body mass index (BMI), systolic blood 
pressure (SBP), diastolic blood pressure (DBP), serum urea and creatinine levels in different study group
NL NH PL PH
Age (years) 33.9 ± 7.3 32.7 ± 8.2 35.8 ± 6.4 34.5 ± 9.7
Parity 4.1 ± 3.8 3.2 ± 3.1 3.7 ± 2.6 3.1 ± 2.1
GA (weeks) 35.6 ± 4.4 34.9 ± 3.3 35.7 ± 3.3 31.7 ± 8.7
BMI 32.1 ± 3.6 32.6 ± 5.6 30.8 ± 4.2 33.6 ± 4.5
SBP (mmHg) 117.05 ± 12.17 111.30 ± 13.62 171.45 ± 19.76*# 182.05 ± 18.94*#
DBP (mmHg) 72.55 ± 7.43 72.10 ± 9.87 118.95 ± 12.26*# 127.20 ± 12.47*#
Serum urea (mg/dl) 27.59 ± 3.47 27.56 ± 3.12 30.67 ± 4.13 31.29 ± 3.92
Serum creatinine (mg/dl) 0.36 ± 0.06 0.84 ± 0.09* 0.72 ± 0.08* 0.86 ± 0.09*
NL normal pregnancy at low altitude group, NH normal pregnancy at high altitude group, PL preeclampsia at low 
altitude group, PH preeclampsia at high altitude group. Results are expressed as mean ± SD (n = 20).  
Significance level is at p < 0.05. * Significantly different from NL group. # Significantly different from NH group. 
± Significantly different from PL group
Determination of urine proteinuria, serum urea and creatinine levels
Urine proteinuria was significantly positive (more than 0.3 gm protein/24 h) in preeclamptic 
groups of both high and low altitude while the normal pregnant women of both groups 
showed absent proteinuria. Serum urea was insignificantly changed in all study groups (27.59 
± 3.47, 27.56 ± 3.12, 30.69 ± 4.14, 31.295 ± 3.9, respectively). Serum creatinine was 
significantly increased in preeclamptic low altitude patients and high altitude normal and 
preeclamptic pregnant women (0.84 ± 0.09, 0.72 ± 0.08, 0.86 ± 0.09 respectively) compared 
with normal pregnant low altitude women (0.36 ± 0.06), while there was no significant 
change comparing the three different groups. In spite of these significant changes in serum 
creatinine, its levels were preserved within the normal values for human indicated no renal 
insult was present in any of the study groups (Table I). 
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Measurement of the systolic and diastolic blood pressure and urinary proteinuria 
confirmed the diagnosis of preeclampsia in PL and PH groups of pregnant patients. 
Determination of both serum urea and creatinine excluded other renal causes of proteinuria 
than the preeclampsia.
Determination of serum ET-1, plasma PGI2 and TXA2 levels 
Serum ET-1 and plasma TXA2 levels in normal pregnant women at high altitude showed a 
significant elevation (66.81 ± 7.36 pg/ml, 122.86 ± 13.37 pg/ml, respectively) compared with 
the normal pregnant women at low altitude (48.92 ± 4.58 pg/ml, 89.03 ± 10.67 pg/ml). 
Preeclampsia in low altitude produced significant increases in both serum ET-1 and plasma 
TXA2 levels (88.39 ± 9.54 pg/ml, 162.73 ± 15.92 pg/ml, respectively) compared with both 
the NL and NH groups. The preeclamptic women at high altitude showed a significant 
elevation of their serum ET-1 and plasma TXA2 levels (117.75 ± 12.96 pg/ml, 211.01 ± 22.69 
pg/ml, respectively) compared with NL, NH and PL groups (Fig. 1A, B). Normal pregnancy 
at high altitude significantly decreased the plasma level of PGI2 (191.57 ± 19.68 pg/ml) 
compared with the normal low altitude pregnant women (238.01 ± 24.55 pg/ml). On the other 
hand, preeclampsia at low altitude resulted in a significant reduction of the plasma level of 
PGI2 (149.155 ± 15.66 pg/ml) compared with both NL and NH groups. Preeclampsia at high 
altitude resulted in a significant reduction of the plasma level of PGI2 (111.92 ± 10.74 pg/ml) 
compared with NL, NH and LP groups of pregnant women (Fig. 1C).
Fig. 1. The effect of high altitude on normal  
and preeclamptic pregnant women on:  
(A) serum endothelin; Plasma levels of  
(B) thromboxane A2 and (C) prostacyclin.  
NL: Normal pregnant women at low altitude;  
NH: Normal pregnant women of at high altitude;  
PL: preeclamptic patient at low altitude;  
PH: preeclamptic patients at high altitude.  
Results are expressed as means ± SD (n = 20). 
Significance was considered when p value was < 0.05.  
(a) Significantly different from NL group.  
 (b) Significantly different from NH group.  
(c) Significantly different from PL group 
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Determination of serum TNF-α and plasma NOx levels
Both TNF-α and plasma NOx levels increased significantly in normal pregnant women at 
high altitude (102.23 ± 13.31 pg/ml, 55.53 ± 6.39 µmol/L, respectively) compared with the 
low altitude normal pregnant group (69.86 ± 7.97 pg/ml, 34.24 ± 4.89 µmol/L, respectively). 
While preeclampsia at low altitude significantly increased the serum TNF-α (142.39 ± 15.37 
pg/ml) without any significant changes in NOx plasma levels (58.94 ± 7.92 µmol/L) compared 
with the NH group. Preeclampsia at high altitude significantly increased both TNF-α and 
plasma NOx levels (196.86 ± 17.64 pg/ml, 97.07 ± 8.59 µmol/L, respectively) compared 
with the NL, NH and PL groups (Fig. 2A, B).
Fig. 2. The effect of high altitude on normal and preeclamptic pregnant women on:  
(A) serum levels of TNF-α and (B) nitrite/nitrate ratio. NL: Normal pregnant women at low altitude;  
NH: Normal pregnant women of at high altitude; PL: preeclamptic patient at low altitude;  
PH: preeclamptic patients at high altitude. Results are expressed as means ± SD (n = 20). Significance was 
considered when p value was < 0.05. (a) Significantly different from NL group. (b) Significantly different from 
NH group. (c) Significantly different from PL group
Discussion
Increased incidence of preeclampsia at high altitude is a well-documented phenomenon 
(1, 20, 36). The present study focused on the mechanisms by which high altitude increases 
maternal risk for the development of preeclampsia through the disturbance in the vasoactive 
mediators. Our results suggests that residence at high altitude enhances vasoconstrictor 
relative to vasodilator mediators and endothelial inflammatory processes in normal pregnancy, 
and more so during preeclampsia as compared to the corresponding states at low altitude. 
Although various researches concerning the cause and mechanism of preeclampsia have 
taken place, its exact pathogenesis remains uncertain. Increased vasoconstriction and 
exaggerated inflammatory response are important contributors to the pathophysiology of 
preeclampsia (32). Several studies support the notion that in preeclampsia, endothelial 
dysfunction involves generalized damage to the maternal endothelium, associated with the 
release of vasoconstrictors, up-regulation inflammatory mediators and imbalance between 
PGI2 and TXA2 (13).
To our knowledge, this is the first study to investigate the changes in TXA2 and PGI2 in 
preeclampsia at high altitude. Our results showed that preeclampsia at low altitude, as 
expected, was associated with increased TXA2 and decreased PGI2 compared to low altitude 
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normal pregnancy. Normal pregnancy at high altitude caused similar but less pronounced 
changes of these factors. However, preeclampsia at high altitude resulted in marked 
augmentation of these vasoactive markers changes (Fig. 1B, C). Lewis et al. suggest that 
during preeclampsia, decreased plasma PGI2 level with increased plasma TXA2 level and the 
imbalance between PGI2 and TXA2 contributes significantly to the increased vasoconstriction 
in both the maternal systemic and the placental vasculatures (22). Normal maternal physiology 
at high altitude could be considered to resemble an intermediate state between preeclampsia 
and normal pregnancy of low altitude (23). Our results suggest that this imbalance is even 
more severe in preeclampsia at high altitude and thus may be a major contributor to the 
altitude associated higher risk of preeclampsia. 
In the current study, ET-1 levels increased significantly in preeclamptic versus normal 
pregnant women at low altitude. The combination of high altitude and preeclampsia produced 
a further significant increase in ET-1 levels (Fig. 1A). This is in agreement with the study of 
Angerio who reported that hypoxia at high altitude induced ET-1 release (1). Several lines of 
evidence suggested a role for ET-1, as potent endothelial derived vasoconstrictor, in the 
pathophysiology of preeclampsia (13). A previous study suggested that ET-1 plays an 
essential role in the failure of trophoblast invasion in the early stages of preeclampsia (12). 
Another study indicated that the level of circulating ET-1 correlates with the severity of the 
disease symptoms (4). Coincidental with the increase in circulating ET-1, Nishikawa et al. 
reported a significant negative correlation between ET-1 levels and levels of the vasodilators 
NO and cGMP in preeclamptic women (24). We observed an increase in serum nitrite/nitrate 
in preeclamptic patients at low altitude and in both normal and preeclamptic pregnancies at 
high altitude (Fig. 2B). This possibly reflects the increased nitric oxide catabolic rate by the 
high oxidative stress level in preeclampsia augmented by high altitude (27). It has been 
reported that under conditions of severe oxidative stress, NO is consumed by superoxide, to 
form highly reactive oxidant species, causing disturbances in the vascular endothelium with 
impairment of its function (30). We suggest that the increased oxidative stress induced by the 
high altitude hypoxia results in hypersecretion of ET-1 with subsequent aggravation of the 
preeclamptic pathophysiological process.
Our study showed elevated TNF-α serum level in preeclamptic high altitude residence 
women compared with lower residence preeclamptic, and normal non-preeclamptic pregnant 
women at both low and high altitude (Fig. 2A). Exaggerated inflammatory responses were 
believed to be a significant pathophysiological event during preeclampsia (25). Several 
biochemical parameters indicate that endothelial dysfunction is related to the inflammatory 
response in preeclampsia, such as elevated serum cellular fibronectin, endothelial adhesion 
molecules P-selectin, the intercellular adhesion molecule, the vascular cell adhesion molecule, 
and the platelet endothelial cell adhesion molecule levels (2, 19, 21, 31, 33). A previous study 
reported that the pro-inflammatory cytokines increased significantly in preeclamptic women 
compared to women with normal pregnancies at sea level (28). The overall profile of cytokine 
production during pregnancy at high altitude is increased by sympatho-adrenal activation 
secondary to the interaction of hypoxia and pregnancy (11). It was reported that maternal 
circulating concentrations of the pro-inflammatory cytokines TNF-α, IL-6, and IL-8 were 
elevated late in normal pregnancy in women residing at high altitude compared to non-
pregnant women (9). The interaction between the inflammatory cytokines and the vasoactive 
mediators has been investigated. Marks et al. have reported that the elevation of pro-
inflammatory cytokine TNF-α induces ET-1 expression and has been linked to an increase in 
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circulating concentrations of endothelial cell adhesion molecules in preeclampsia especially 
at high altitude (23). Therefore, combining the effect of high altitude to that of preeclampsia 
can be expected to produce a marked elevation in these inflammatory cytokines.
Our study demonstrates that residence at high altitude is associated with enhanced 
production of TXA2, decreased PGI2 as well as increased levels of ET-1 and TNF-α during 
normal pregnancy, and more so during preeclampsia. Further research is needed to identify 
which of the markers of vascular dysfunction will be useful in early detection and follow up 
of preeclamptic women at high altitude. The result suggests that the management of 
preeclampsia at high altitude may require movement to a lower altitude. However, we would 
like to extend our studies to investigate whether the suggested therapeutic approaches like 
low dose aspirin, to readjust the balance in favor of production of more PGI2 relative to TXA2 
(8), or ET-1 receptor antagonists (14), would also work at high altitude. 
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